Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Ads
      related to macular degeneration
    1. Yahoo Finance Results

    2. Frost & Sullivan's Visionary Science team has calculated the economic burden of addressing cases of AMD among this population and discovered that the total cost of managing the consequences ...

    3. Frost & Sullivan's Visionary Science team has calculated the economic burden of addressing cases of AMD among this population and discovered that the total cost of managing the consequences ...

    4. Menendez Vowed a Cabinet-Level Push to Help a Friend, Jury Hears

      Bloomberg via Yahoo FinanceOct 03 18:31 PM

      Senator Robert Menendez pressed a senior Obama administration official to change Medicare policy in a way that would benefit a close friend accused of overbilling the government by $8.9 million, jurors ...

    5. We received Fast Track designation for elamipretide for the treatment of PMM from the FDA in December 2015. We are developing our second product candidate, SBT-20, for central nervous system ...

    6. ForeseeHome is the only device proven in a randomized controlled clinical trial to detect the onset of wet AMD earlier than standard care. Patients using ForeseeHome had significantly...

    7. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related ...

    8. LOUISVILLE, Colo., Oct. 04, 2017-- AntriaBio, Inc., a biopharmaceutical company focused on developing platform technologies to target significant unmet medical needs, today announced the appointment of ...

    9. Aerie Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with ...

    10. PanOptica, Inc., a private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that it has secured $11 million in a Series B financing.

    11. OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases, today announced ...

    1. Ads
      related to macular degeneration
    2. See more ads for: